APA (7th ed.) Citation

Coyle, T. E., Reding, M. T., Lin, J. C., Michaels, L. A., Shah, A., & Powell, J. (2014). Phase I study of BAY 94‐9027, a PEGylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia A. Journal of thrombosis and haemostasis, 12(4), 488-496. https://doi.org/10.1111/jth.12506

Chicago Style (17th ed.) Citation

Coyle, T. E., M. T. Reding, J. C. Lin, L. A. Michaels, A. Shah, and J. Powell. "Phase I Study of BAY 94‐9027, a PEGylated B‐domain‐deleted Recombinant Factor VIII with an Extended Half‐life, in Subjects with Hemophilia A." Journal of Thrombosis and Haemostasis 12, no. 4 (2014): 488-496. https://doi.org/10.1111/jth.12506.

MLA (9th ed.) Citation

Coyle, T. E., et al. "Phase I Study of BAY 94‐9027, a PEGylated B‐domain‐deleted Recombinant Factor VIII with an Extended Half‐life, in Subjects with Hemophilia A." Journal of Thrombosis and Haemostasis, vol. 12, no. 4, 2014, pp. 488-496, https://doi.org/10.1111/jth.12506.